Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R MacRae

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Seminars in Perinatology|August 18, 2005
Second trimester serum markersJacob A Canick, Andrew R MacRae
Circulation|February 15, 2012
Letter by Kavsak and MacRae regarding article, "Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction"Peter A Kavsak, Andrew R MacRae
Clinical Chemistry|January 27, 2009
Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injuryPeter A Kavsak, Andrew R MacRae, Marie-Jeanne Yerna, et al.
Clinical Chemistry|January 1, 2003
Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening applicationAndrew R MacRae, H Allen Gardner, Lynn C Allen, et al.
Clinical Chemistry|August 15, 2009
Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain populationPeter A Kavsak, Xuesong Wang, Dennis T Ko, et al.
Clinical Chemistry|January 16, 2010
2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assayPeter A Kavsak, Dennis T Ko, Xuesong Wang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 12, 2017
Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10yearsPeter A Kavsak, Andrew Worster, Stephen A Hill, et al.
Clinical Chemistry|October 14, 2010
Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohortPeter A Kavsak, Dennis T Ko, Xuesong Wang, et al.
Clinical Biochemistry|November 17, 2009
The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency departmentPeter A Kavsak, Alice M Newman, Dennis T Ko, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 4, 2009
Another potential marker linking gender and cardiac mortality: PAPP-A--a new marker in risk stratification for women presenting with chest painPeter A Kavsak, Matthew Henderson, Dennis T Ko, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Seminars in Perinatology|August 18, 2005
Second trimester serum markersJacob A Canick, Andrew R MacRae
Circulation|February 15, 2012
Letter by Kavsak and MacRae regarding article, "Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction"Peter A Kavsak, Andrew R MacRae
Clinical Chemistry|January 27, 2009
Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injuryPeter A Kavsak, Andrew R MacRae, Marie-Jeanne Yerna, et al.
Clinical Chemistry|January 1, 2003
Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening applicationAndrew R MacRae, H Allen Gardner, Lynn C Allen, et al.
Clinical Chemistry|August 15, 2009
Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain populationPeter A Kavsak, Xuesong Wang, Dennis T Ko, et al.
Clinical Chemistry|January 16, 2010
2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assayPeter A Kavsak, Dennis T Ko, Xuesong Wang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 12, 2017
Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10yearsPeter A Kavsak, Andrew Worster, Stephen A Hill, et al.
Clinical Chemistry|October 14, 2010
Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohortPeter A Kavsak, Dennis T Ko, Xuesong Wang, et al.
Clinical Biochemistry|November 17, 2009
The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency departmentPeter A Kavsak, Alice M Newman, Dennis T Ko, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 4, 2009
Another potential marker linking gender and cardiac mortality: PAPP-A--a new marker in risk stratification for women presenting with chest painPeter A Kavsak, Matthew Henderson, Dennis T Ko, et al.
Pageof 3